Virginia Retirement Systems Et Al Halozyme Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

$15 Billion
Q3 2025

A detailed history of Virginia Retirement Systems Et Al transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 27,219 shares of HALO stock, worth $1.91 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

27,219

Previous 39,419 30.95%

Holding current value

$1.91 Million

Previous $2.05 Million 2.63%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$52.92 - $78.28 $645,624 - $955,016	-12,200 Reduced 30.95%	27,219 $2 Million
Q2 2025 Jul 29, 2025	BUY	$47.91 - $70.14 $776,142 - $1.14 Million	16,200 Added 69.77%	39,419 $2.05 Million
Q1 2025 Jul 16, 2025	BUY	$47.74 - $65.16 $344,635 - $470,390	7,219 Added 45.12%	23,219 $1.48 Million
Q3 2023 Jan 02, 2024	BUY	$36.46 - $44.03 $200,530 - $242,165	5,500 Added 52.38%	16,000 $611,000
Q2 2023 Aug 22, 2023	SELL	$30.28 - $38.74 $6.04 Million - $7.73 Million	-199,500 Reduced 95.0%	10,500 $378,000
Q1 2023 Jul 11, 2023	SELL	$32.86 - $55.7 $16,430 - $27,850	-500 Reduced 0.24%	210,000 $8.02 Million
Q4 2022 May 17, 2023	BUY	$40.06 - $59.44 $7.46 Million - $11.1 Million	186,300 Added 769.83%	210,500 $12 Billion
Q3 2022 May 16, 2023	SELL	$38.53 - $51.78 $339,064 - $455,664	-8,800 Reduced 26.67%	24,200 $957 Million
Q1 2022 Apr 21, 2022	BUY	$31.97 - $41.06 $22,379 - $28,742	700 Added 2.17%	33,000 $1.32 Million
Q4 2021 Feb 03, 2022	BUY	$31.82 - $40.75 $334,110 - $427,875	10,500 Added 48.17%	32,300 $1.3 Million
Q3 2021 Oct 21, 2021	BUY	$38.47 - $46.42 $607,826 - $733,436	15,800 Added 263.33%	21,800 $887,000
Q2 2021 Aug 13, 2021	SELL	$38.84 - $51.31 $621,440 - $820,960	-16,000 Reduced 72.73%	6,000 $272,000
Q1 2021 Apr 30, 2021	SELL	$39.51 - $51.45 $845,514 - $1.1 Million	-21,400 Reduced 49.31%	22,000 $917,000
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $7,743 - $13,086	300 Added 0.7%	43,400 $1.85 Million
Q3 2020 Nov 12, 2020	SELL	$25.74 - $29.63 $450,450 - $518,525	-17,500 Reduced 28.88%	43,100 $1.13 Million
Q2 2020 Aug 12, 2020	BUY	$16.25 - $26.81 $393,250 - $648,802	24,200 Added 66.48%	60,600 $1.63 Million
Q1 2020 May 12, 2020	BUY	$13.9 - $21.83 $505,960 - $794,611	36,400 New	36,400 $655,000

Others Institutions Holding HALO

# of Institutions

653

Shares Held

155M

Call Options Held

593K

Put Options Held

471K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.75B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Halozyme Therapeutics, Inc. Transaction History